Table 2.
Associated with time to clearance | Associated with early clearance | Associated with late clearance | |
---|---|---|---|
CD158a | * | * | |
KIR3DL1 | * | ||
NKG2A | |||
NKp46 | * | ||
CD158b | * | ||
CD161 | |||
Perforin | * | ||
NKG2D | * | * | |
CD94 | |||
2B4 | * | * | |
NKp30 | |||
TRAIL | * | ||
CD160 |
Associated with time to clearance | Associated with early clearance | Associated with late clearance | |
---|---|---|---|
CD158a | * | * | |
KIR3DL1 | * | ||
NKG2A | |||
NKp46 | * | ||
CD158b | * | ||
CD161 | |||
Perforin | * | ||
NKG2D | * | * | |
CD94 | |||
2B4 | * | * | |
NKp30 | |||
TRAIL | * | ||
CD160 |